Literature DB >> 7271292

Transient neonatal hyperparathyroidism secondary to maternal pseudohypoparathyroidism.

E J Glass, D G Barr.   

Abstract

A neonate was found to have normocalcaemic hyperparathyroidism with bone disease. The plasma parathyroid hormone concentration returned to normal by 4 weeks, and healing of the bone lesions was evident by age 5 months. The mother proved to have pseudohypoparathyroidism, previously unsuspected.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7271292      PMCID: PMC1627360          DOI: 10.1136/adc.56.7.565

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Transient neonatal hyperparathyroidism associated with maternal hypoparathyroidism.

Authors:  E Goldberg; S T Winter; O S Better; A Berger
Journal:  Isr J Med Sci       Date:  1976-03

2.  Intra-uterine hyperparathyroidism secondary to maternal hypoparathyroidism.

Authors:  D Bronsky; R T Kiamko; R Moncada; I M Rosenthal
Journal:  Pediatrics       Date:  1968-10       Impact factor: 7.124

3.  Congenital hyperparathyroidism secondary to maternal hypoparathyroidism.

Authors:  B H Landing; S Kamoshita
Journal:  J Pediatr       Date:  1970-11       Impact factor: 4.406

4.  Congenital hyperparathyroidism and vitamin D deficiency secondary to maternal hypoparathyroidism.

Authors:  L Sann; L David; A Thomas; A Frederich; M C Chapuy; R François
Journal:  Acta Paediatr Scand       Date:  1976-05

5.  Intrauterine hyperparathyroidism: a complication of untreated maternal hypoparathyroidism.

Authors:  T Aceto; R E Batt; E Bruck; R B Schultz; Y R Perz
Journal:  J Clin Endocrinol Metab       Date:  1966-05       Impact factor: 5.958

6.  A simplified assessment of response to parathyroid hormone in hypoparathyroid patients.

Authors:  S Tomlinson; G N Hendy; J H O'Riordan
Journal:  Lancet       Date:  1976-01-10       Impact factor: 79.321

  6 in total
  8 in total

Review 1.  Hypercalcemia in children and adolescents.

Authors:  Steven A Lietman; Emily L Germain-Lee; Michael A Levine
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

2.  Transient neonatal hyperparathyroidism secondary to maternal pseudohypoparathyroidism.

Authors:  S Ozsoylu
Journal:  Arch Dis Child       Date:  1982-03       Impact factor: 3.791

Review 3.  Hypercalcemia: a consultant's approach.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2017-09-06       Impact factor: 3.714

4.  Prolonged spontaneous normocalcaemia in pseudohypoparathyroidism from resorption of soft tissue calcium deposits: a cautionary tale.

Authors:  Erin E Carter; Gregory Kline
Journal:  BMJ Case Rep       Date:  2014-01-30

Review 5.  Global Consensus Recommendations on Prevention and Management of Nutritional Rickets.

Authors:  Craig F Munns; Nick Shaw; Mairead Kiely; Bonny L Specker; Tom D Thacher; Keiichi Ozono; Toshimi Michigami; Dov Tiosano; M Zulf Mughal; Outi Mäkitie; Lorna Ramos-Abad; Leanne Ward; Linda A DiMeglio; Navoda Atapattu; Hamilton Cassinelli; Christian Braegger; John M Pettifor; Anju Seth; Hafsatu Wasagu Idris; Vijayalakshmi Bhatia; Junfen Fu; Gail Goldberg; Lars Sävendahl; Rajesh Khadgawat; Pawel Pludowski; Jane Maddock; Elina Hyppönen; Abiola Oduwole; Emma Frew; Magda Aguiar; Ted Tulchinsky; Gary Butler; Wolfgang Högler
Journal:  J Clin Endocrinol Metab       Date:  2016-01-08       Impact factor: 5.958

Review 6.  Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature.

Authors:  Elena Tsourdi; Athanasios D Anastasilakis
Journal:  Biomedicines       Date:  2021-04-26

7.  Primary hyperparathyroidism: an overview.

Authors:  Jessica Mackenzie-Feder; Sandra Sirrs; Donald Anderson; Jibran Sharif; Aneal Khan
Journal:  Int J Endocrinol       Date:  2011-06-02       Impact factor: 3.257

Review 8.  Hypoparathyroidism in Pregnancy and Lactation: Current Approach to Diagnosis and Management.

Authors:  Dalal S Ali; Karel Dandurand; Aliya A Khan
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.